Keyphrases
COVID-19
100%
Antidepressants
100%
Clinical Evidence
100%
COVID-19 Infection
40%
Ongoing Clinical Trials
30%
Fluvoxamine
20%
Antiviral Activity
10%
Mental Disorders
10%
Development Strategy
10%
COVID-19 Pandemic
10%
Repurposing
10%
Placebo
10%
Anti-inflammatory Effect
10%
Phase II Study
10%
MEDLINE
10%
Narrative Review
10%
Hospitalization Rate
10%
Phase II Clinical Trial
10%
Preclinical Data
10%
Tramadol
10%
Fluoxetine
10%
Electronic Search
10%
Clinical Deterioration
10%
Existing Drugs
10%
COVID-19 Patients
10%
Deterioration Rate
10%
MedRxiv
10%
BioRxiv
10%
Therapeutic Dilemma
10%
Pharmacology, Toxicology and Pharmaceutical Science
Antidepressant
100%
Antidepressant
100%
Clinical Trial
44%
Infection
44%
Observational Study
22%
Anti-Inflammatory Drug
22%
Fluvoxamine
22%
Antiviral Activity
11%
Preclinical Study
11%
Repurposing
11%
Disease
11%
SARS Coronavirus
11%
Placebo
11%
Fluoxetine
11%
Cytokine
11%
Antivirus Agent
11%
Deterioration
11%
Tramadol
11%
Pandemic
11%